HomeQuestion

Is there increased risk from RT in patients with FAP (familial adenomatous polyposis)?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Are you incorporating TTFields into treatment protocols for locally advanced pancreatic cancer based on the PANOVA-3 study?

Given that ESOPEC did not mandate PET staging, are the conclusions of the study still applicable for patients who are staged with PET?

If a patient with initially borderline resectable pancreatic cancer receives neoadjuvant CHT followed by CRT and is ultimately deemed unresectable, do you consider an RT boost?

How do you counsel patients on imaging findings after liver SBRT for HCC, particularly with regard to expectations on timing to tumor resolution?

Would you consider SBRT for fibrolamellar HCC that is inoperable?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.